(Untitled)

Welcome to my Drug Sciences Hub

I help make sure medicines are safe for the people who rely on them, combining more than ten years of hospital and community pharmacy with research into drug-induced immune responses.

Trusted by

I can describe Elena as a friendly kind, trustworthy, relaxed, and mature person who treats people with respect and kindness.

Katerina Oliphant, Pharmacist

As a pharmacist she knows to treat all patients with empathy, making complete and complex pharmaceutical

Dr. Elena Gheorghiu, Senior Pharmacist

Mrs. Pintea showed a high level of knowledge in the pharmaceutical domain, with developed interpersonal skills with regards to her colleagues and took part in team activities revealing her team spirit.

Coinac Tatiana, Director Farmacia “Receta Farm” SRL

Latest

Oct 14
A map of the nonclinical safety package

A map of the nonclinical safety package: what ICH M3(R2) requires before first-in-human dosing

Before a new medicine is given to a human for the first time, regulators expect a defined set of nonclinical
4 min read
Oct 14
More than sixty years later, they shape how drug developers design safety programmes, and they are moving from an ethical principle to a regulatory reality.

The 3Rs in practice: where in vitro models like macrophage assays fit in early safety assessment

The 3Rs, Replacement, Reduction and Refinement, were proposed by William Russell and Rex Burch in 1959 (Russell & Burch, 1959)
4 min read
Oct 14
Interactions as safety signals - how DDI case reports feed pharmacovigilance

Interactions as safety signals: how DDI case reports feed pharmacovigilance

Some of the best-known drug withdrawals were not about a single drug. They were about combinations.
4 min read
Oct 14
Pharmacogenomics at the counter

Pharmacogenomics at the counter: when a patient's genes change the interaction picture

Most interaction checks look at drug against drug. Pharmacogenomics adds a third factor: the patient's own genes.
3 min read
Oct 14
Five drug interactions I check for every day in a Swiss community pharmacy

Five drug interactions I check for every day in a Swiss community pharmacy

Interaction software in a pharmacy flags dozens of alerts a day. Most are minor. The skill lies in recognising the
4 min read
Oct 14
Why ADRs are under-reported, and what pharmacists can do about it

Why ADRs are under-reported, and what pharmacists can do about it

Spontaneous reporting is still one of the most important ways to detect new drug safety problems. Yet most suspected adverse drug reactions are never reported.
4 min read
Oct 14
What makes a valid ICSR

What makes a valid ICSR? The four minimum criteria, explained with pharmacy examples

Every pharmacovigilance system is built on one unit of information: the individual case safety report, or ICSR. Before a case can be assessed, coded or reported to an authority, someone has to decide whether it is valid.
4 min read